share_log

Galectin Therapeutics | 3: Initial statement of beneficial ownership of securities-Director CARSON BENJAMIN SR

SEC announcement ·  Feb 16 08:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more